Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Stulc

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Vnitrni Lekarstvi|September 8, 2009
[Lipid-lowering treatment in metabolic syndrome]T Stulc, R Cecka
Ceska Gynekologie|September 29, 1998
[Receptors and mechanisms of action of estrogen in bones]T Stulc, J Stĕpán
Casopis Lekaru Ceskych|August 23, 2000
[Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic]R Ceska, T Stulc
Physiological Research|November 13, 2001
Cholesterol lowering and the vessel wall: new insights and future perspectivesT Stulc, R Ceska
International Angiology : a Journal of the International Union of Angiology|September 15, 2005
Matrix metalloproteinases in isolated hypercholesterolemiaJ Malik, T Stulc, R Ceska
Physiological Research|November 10, 2000
Bone mineral density in patients with apolipoprotein E type 2/2 and 4/4 genotypeT Stulc, R Ceska, A Horínek, et al.
Casopis Lekaru Ceskych|August 23, 2000
[Hyperlipoproteinemia, the Apo-E genotype and bone density]T Stulc, R Ceska, A Horínek, et al.
Pharmacology & Toxicology|June 1, 1997
Comparative study on the effect of calcium channel blockers on basal and parathyroid hormone-induced bone resorption in vitroK Redlich, P Pietschmann, T Stulc, et al.
Biochimica Et Biophysica Acta|March 27, 1997
Immunocytochemical detection of estrogen receptors in bone cells using flow cytometryT Stulc, D Klement, J Kvasnicka, et al.
Physiological Research|October 11, 2003
Familial dysbetalipoproteinemia in three patients with apoE 2*(Arg136-->Cys) gene variantM Vrablík, A Horínek, R Ceska, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Vnitrni Lekarstvi|September 8, 2009
[Lipid-lowering treatment in metabolic syndrome]T Stulc, R Cecka
Ceska Gynekologie|September 29, 1998
[Receptors and mechanisms of action of estrogen in bones]T Stulc, J Stĕpán
Casopis Lekaru Ceskych|August 23, 2000
[Fenofibrate 250 SR Pharmavit in patients with mixed hyperlipoproteinemia. Results of a study of 189 patients from 13 centers in the Czech Republic]R Ceska, T Stulc
Physiological Research|November 13, 2001
Cholesterol lowering and the vessel wall: new insights and future perspectivesT Stulc, R Ceska
International Angiology : a Journal of the International Union of Angiology|September 15, 2005
Matrix metalloproteinases in isolated hypercholesterolemiaJ Malik, T Stulc, R Ceska
Physiological Research|November 10, 2000
Bone mineral density in patients with apolipoprotein E type 2/2 and 4/4 genotypeT Stulc, R Ceska, A Horínek, et al.
Casopis Lekaru Ceskych|August 23, 2000
[Hyperlipoproteinemia, the Apo-E genotype and bone density]T Stulc, R Ceska, A Horínek, et al.
Pharmacology & Toxicology|June 1, 1997
Comparative study on the effect of calcium channel blockers on basal and parathyroid hormone-induced bone resorption in vitroK Redlich, P Pietschmann, T Stulc, et al.
Biochimica Et Biophysica Acta|March 27, 1997
Immunocytochemical detection of estrogen receptors in bone cells using flow cytometryT Stulc, D Klement, J Kvasnicka, et al.
Physiological Research|October 11, 2003
Familial dysbetalipoproteinemia in three patients with apoE 2*(Arg136-->Cys) gene variantM Vrablík, A Horínek, R Ceska, et al.
Pageof 3